Frequency of recurrence following cardioversion of an initial atrial fibrillation episode

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Keisuke Usuda

Broad Institute of MIT and Harvard, Cambridge (United States of America)

5 More presentations in this session

Presentation thumbnail

Joint relevance of CYP2D6 and H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study.

Mr M. Trincado Ave (Santiago de Compostela, ES)

Abstract Slides Video

Presentation thumbnail

Efficacy and safety of catheter ablation versus antiarrhythmic drug therapy in ventricular tachycardia management: a systematic review and meta-analysis

Doctor L. Lucena (Florianopolis, BR)

Abstract Slides Video

Presentation thumbnail

Safety outcomes of catheter ablation versus antiarrhythmic drugs in atrial fibrillation: a comprehensive systematic review and meta-analysis

Doctor M. SHAWKI (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Rate vs. rhythm control in patients with transthyretin amyloid cardiomyopathy and atrial fibrillation

Doctor P. Lustig (Vienna, AT)

Abstract Slides Video

Presentation thumbnail

Prevention of atrial fibrillation recurrence with vitamin C during catheter ablation

Doctor A. Tian (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Treatment of atrial fibrillation: there is more than ablation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Treatment of atrial fibrillation: there is more than ablation

Congress Session

New insights in catheter ablation of atrial fibrillation

Congress Session

Atrial fibrillation: clinical 1

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources